FeesSafety
Pluang+

Perspective Therapeutics reports strong 3Q 2026 results with $202M cash, advancing cancer drug trials and FDA Fast Track status.

Company Fundamentals
09 Nov 2026, 23:30 WIB
GlobeNewsWire
View Source
Bullish
Perspective Therapeutics reports strong 3Q 2026 results with $202M cash, advancing cancer drug trials and FDA Fast Track status.

Perspective Therapeutics announced its third quarter 2026 results, highlighting $202 million in cash and investments to fund operations through 2028. The company reported progress in its cancer drug pipeline, including positive interim data for bamzireotide navoxetan in neuroendocrine tumors, promising melanoma treatment results with lapemelanotide zapixetar, and Fast Track designation from the FDA for PSV359 in FAP-positive tumors. Collaboration with Merck to evaluate PSV359 with Keytruda in lung and colorectal cancers was also noted. The company plans an FDA meeting in early 2027 and aims to complete manufacturing site construction by early 2027.

Perspective Therapeutics' recent business highlights and 3Q 2026 results provide context for readers following health-sector developments. For readers following health stocks, here is Pluang's market snapshot as of Nov 10, 2026 04:11 WIB: out of 150 priced US health-sector stocks tradable on Pluang, 125 rose and 23 fell today. Notable movers include Ginkgo Bioworks Holdings Inc (DNA) at USD 12.41 with a 9.92% increase and 100% buy order activity, Summit Therapeutics Inc (SMMT) at USD 17.90 up 9.61% with 98% buy orders, and Cassava Sciences Inc (FLNA) at USD 0.50 rising 9.52% but with 88% sell orders. Typical hold times range from 9 to 39 days.

More News

India's paints and coatings market to reach $21.17B by 2032, driven by construction and automotive growth.

India's paints and coatings market to reach $21.17B by 2032, driven by construction and automotive growth.

The India paints and coatings market is projected to grow from $12.51 billion in 2026 to $21.17 billion by 2032, at a CAGR of 9.14%. Growth is fueled by expanding residential construction, rising demand for decorative repainting, and increased automo...

Market News
Bullish
1 hour ago
INVE Technologies partners with Trackonomy to integrate Physical AI into enterprise software.

INVE Technologies partners with Trackonomy to integrate Physical AI into enterprise software.

INVE Technologies has formed a strategic partnership with Trackonomy to integrate Trackonomy's Physical AI platform into INVE's acquired enterprise software products. This collaboration aims to enhance software offerings with real-world operational d...

Market News
Bullish
1 hour ago
AmpliTech Group to release Q3 2026 results and hold earnings call on Nov 12

AmpliTech Group to release Q3 2026 results and hold earnings call on Nov 12

AmpliTech Group, a company specializing in RF and microwave components for telecom and defense, will announce its third quarter 2026 financial results on November 12, 2026, after market close. The company will host a conference call at 5:00 PM ET the...

Company Fundamentals
Neutral
2 hours ago
Toll Brothers opens luxury model homes at Hidden Vista, Palm Desert, starting from $1M

Toll Brothers opens luxury model homes at Hidden Vista, Palm Desert, starting from $1M

Toll Brothers has announced the grand opening of new luxury single-story model homes at Hidden Vista, a gated community in Palm Desert, California, on November 14. These homes offer up to 2,700 sq ft with 3-4 bedrooms, modern open floor plans, and pr...

Market News
Bullish
3 hours ago
FocusReactive tops six major platforms in 2026 for Next.js, headless CMS, and web development excellence.

FocusReactive tops six major platforms in 2026 for Next.js, headless CMS, and web development excellence.

FocusReactive, a web development agency specializing in Next.js and headless CMS, achieved top rankings across six major industry review platforms in 2026, including Clutch, DesignRush, and The Manifest. The agency was recognized globally for experti...

Others
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App